Altered motor nerve excitability in end-stage kidney disease.
Although multiple toxins have been implicated in the development of uraemic neuropathy, no causative agent has been identified. In the present study, the excitability properties of lower limb motor nerves in patients with end-stage kidney disease treated with haemodialysis were measured before, during and after a standard 5 h haemodialysis session, in an attempt to explore the pathophysiology of uraemic neuropathy. Compound muscle action potentials were recorded from tibialis anterior and extensor digitorum brevis, following stimulation of the common peroneal nerve in 14 patients. Measures of excitability were assessed in relation to changes in serum levels of potential neurotoxins, including potassium, calcium, urea, uric acid, parathyroid hormone and beta-2-microglobulin. Before dialysis, measures of nerve excitability were significantly abnormal in the patient group for axons innervating tibialis anterior and extensor digitorum brevis, consistent with axonal depolarization: refractoriness was increased and superexcitability and depolarizing threshold electrotonus were reduced. Pre-dialysis excitability abnormalities were strongly correlated with serum K+. Correlation was also noted between the severity of symptoms and excitability abnormalities. Haemodialysis normalized the majority of nerve excitability parameters. In conclusion, lower limb motor axons in uraemic patients are depolarized before dialysis. The correlation between serum K+ and excitability measures indicates that hyperkalaemia is primarily responsible for uraemic depolarization, and a likely contributing factor to the development of neuropathy.
Krishnan
Arun V
AV
Institute of Neurological Sciences, Prince of Wales Hospital, Randwick, Sydney, Australia.
Phoon
Richard K S
RK
Pussell
Bruce A
BA
Charlesworth
John A
JA
Bostock
Hugh
H
Kiernan
Matthew C
MC
D000200:Action Potentials; D000293:Adolescent; D000328:Adult; D000368:Aged; D004558:Electric Stimulation / Q000379:methods; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000503:physiopathology* / Q000628:therapy; D007866:Leg / Q000294:innervation; D008297:Male; D008875:Middle Aged; D009046:Motor Neurons / Q000502:physiology*; D009431:Neural Conduction; D009498:Neurotoxins / Q000097:blood; D010523:Peripheral Nervous System Diseases / Q000097:blood / Q000209:etiology / Q000503:physiopathology*; D011188:Potassium / Q000097:blood; D006435:Renal Dialysis
D009498:Neurotoxins; D011188:Potassium